Valuation : Berkley Renewables Inc.

Market Cap 364K 314K 297K 269K 506K 34.81M 508K 3.53M 1.36M 17.71M 1.37M 1.34M 55.97M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.42M 4.18M 3.79M 7.11M 490M 7.15M 49.66M 19.1M 249M 19.25M 18.83M 787M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 20/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 17/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+0.23%+2.30%+48.60%+11.59% 165B
-0.44%-0.66%+60.43%+57.96% 103B
-0.07%+1.49%+24.71%+9.90% 77.29B
+0.49%+2.37%+34.57%-7.48% 61.44B
-0.58%+2.36%+96.28%+64.19% 61.01B
+0.42%+4.52%+44.46%-2.26% 57.76B
-0.20%+2.89%+49.74%+31.13% 57.4B
-0.18%+3.24%+35.67%-12.82% 44.8B
-2.15%+1.11%+52.51%+11.29% 36.48B
Average -0.25%+1.69%+49.66%+18.17% 66.42B
Weighted average by Cap. -0.14%+1.79%+49.82%+20.47%

Financials

2016 2017
Net sales 1.03M 891K 844K 765K 1.43M 98.79M 1.44M 10.02M 3.85M 50.26M 3.88M 3.8M 159M 1.72M 1.49M 1.41M 1.28M 2.39M 165M 2.4M 16.71M 6.43M 83.83M 6.48M 6.34M 265M
Net income 173K 149K 141K 128K 240K 16.5M 241K 1.67M 643K 8.39M 649K 634K 26.52M -631K -543K -514K -466K -875K -60.24M -879K -6.11M -2.35M -30.65M -2.37M -2.32M -96.84M
Net Debt 2.92M 2.51M 2.38M 2.16M 4.05M 279M 4.07M 28.26M 10.87M 142M 10.96M 10.71M 448M 4.76M 4.1M 3.88M 3.52M 6.61M 455M 6.64M 46.13M 17.74M 231M 17.88M 17.49M 731M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!